|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Avista Capital Partners, a private equity firm. |
|---|---|
| Transferring Party | Boston Scientific Corp. (NYSE: BSX), a manufacturer of medical device products for interventional medical specialties. |
| Sector | Medical Devices |
| Date | December 14, 2007 |
| Analysis Part of Boston Scientific's plan to divest non-strategic assets. The fluid management and venous access businesses serve as a key high growth platform for Avista. Deal value -- $425m. Avista also agreed to the Medical Imaging unit of Bristol-Myers for $525, making 2 big PE deals amid a difficult credit environment. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |